SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-24-015062
Filing Date
2024-03-25
Accepted
2024-03-25 17:15:40
Documents
6
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20016521x1_pre14a.htm PRE 14A 962499
2 logo_cytomx2.jpg GRAPHIC 31776
3 ny20016521x1-pc_1.jpg GRAPHIC 491325
4 ny20016521x1-pc_2.jpg GRAPHIC 537473
5 ny20016521x1_pvpchart01x1.jpg GRAPHIC 158682
6 ny20016521x1_pvpchart02x1.jpg GRAPHIC 141393
  Complete submission text file 0001140361-24-015062.txt   2836498
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37587 | Film No.: 24780152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)